Market Research Logo

In-Vitro Colorectal Cancer Screening Tests Market Size by Test Type (Fecal Occult Blood Tests [Guaiac FOB Stool, Immuno-FOB Agglutination, Lateral Flow Immuno-FOB, Immuno-FOB ELISA], Biomarker Tests [Tumor M2-PK Stool, Transferrin Assays], CRC DNA Screeni

In-Vitro Colorectal Cancer Screening Tests Market Size by Test Type (Fecal Occult Blood Tests [Guaiac FOB Stool, Immuno-FOB Agglutination, Lateral Flow Immuno-FOB, Immuno-FOB ELISA], Biomarker Tests [Tumor M2-PK Stool, Transferrin Assays], CRC DNA Screening Tests [Methylated Gene Testing, Panel DNA Tests]), Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, France, Italy, Spain, Japan, China, India, Australia, Brazil, Mexico, South Africa, Saudi Arabia) Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2025

In-vitro Colorectal Cancer Screening Tests Market will exceed USD 1.3 billion by 2025; as per a new research report.

Increasing geriatric population base, at higher risk of acquiring colorectal cancer will drive in-vitro colorectal cancer screening tests market growth. Adoption of sedentary lifestyle along with an increase in chronic conditions like type 2 diabetes, inflammatory bowel disease and obesity will boost colorectal cancer incidence. Increased incidence and improved diagnostics tests will contribute to market growth.

Molecular screening and DNA testing are being used today and are gaining significant importance along with becoming essential part of routine patient care. Assessing at-risk individuals for inherited colorectal cancer is predicted to transfer from individual gene testing that is generally done today to whole genome or whole exome sequencing, that will offer supplementary data of the patient’s genome that cannot be directly related to the colorectal cancer syndrome. Growing advancement in efficient patient management and expansion of screening activities, and technological development in cancer screening as a key health care tool will propel the in-vitro colorectal cancer screening market growth.

Fecal occult blood tests (FOBT) accounted for 83.8% revenue share in 2018 and is estimated to grow with the robust CAGR of 4.7%. The cost effectiveness and ease of use pertaining to the FOBT tests will primarily drive the segment growth over the forecast timeframe. Immuno-FOB agglutination and test Immuno-FOB ELISA sub segments are majorly contributing to the growth of the segment. Furthermore, increasing specificity and sensitivity of stool-based test will further boost the adoption rates rendering significant positive impact on the market growth.

Immuno-FOB agglutination and test Immuno-FOB ELISA are the major revenue generating segment in fecal occult blood. Cost effective tests and easy to use, are the major factors driving In-vitro colorectal cancer screening test market growth over the forecast period. Stool-based screening sensitivity and specificity has been improved due to introduction of Immuno-FOBT for initial detection of colorectal cancer and advanced adenomas.

Increasing geriatric population, greater susceptibility of the elderly towards disease acquisition will drive the North America in-vitro colorectal cancer screening tests market. Europe in-vitro colorectal cancer screening tests market was valued at USD 337.4 million in 2018 and is expected to grow at a CAGR of 5.0% by 2025. Growing risk factors like age, race, changing behavior associated with high-income countries, such as western diet, sedentary lifestyle and smoking are the major factors causing colorectal cancer. The prevalence of these factors is reflected in the substantial variation in colorectal cancer incidence worldwide, which is highest in Europe and North America

The major industry players in the in-vitro colorectal cancer screening tests market are Siemens Healthcare, Abbott Molecular, EMD Millipore, Qiagen, Alere, Beckman Coulter and Eiken Chemical among others. Competition among the firms is essentially centered around quality and price of the products. Furthermore, the firms are focusing on rigorous research and development activities to develop advanced tests capable of delivering accurate results instantly.


Chapter 1. Methodology
1.1. Methodology
1.2. Market definition
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. In-Vitro colorectal cancer screening tests industry 360 degree synopsis, 2014 - 2025
2.1.1. Business trends
2.1.2. Test type trends
2.1.3. Regional trends
Chapter 3. In-Vitro Colorectal Cancer Screening Tests Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2014 - 2025
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Improvements in colorectal cancer screening through non-invasive methods
3.3.1.2. Advancements in the field of diagnosis
3.3.1.3. Rising prevalence of colorectal cancer
3.3.1.4. Cost-efficient and High-speed DNA sequencing
3.3.2. Industry pitfalls & challenges
3.3.2.1. Lack of uniform cancer screening guidelines in Asia Pacific
3.3.2.2. Inadequate reimbursement coverage
3.3.2.3. Shortage of trained staff in developing regions
3.4. Regulatory landscape
3.4.1. U.S.
3.4.2. Europe
3.4.3. China
3.5. Technology landscape
3.6. Growth potential analysis
3.6.1. By test type
3.7. Porter's analysis
3.8. Competitive landscape, 2017
3.8.1. Strategy dashboard
3.9. PESTEL analysis
Chapter 4. In-Vitro Colorectal Cancer Screening Tests Market, By Test Type
4.1. Key segment trends
4.2. Fecal occult blood test (FOBT)
4.2.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)
4.2.2. Guaiac FOB stool test
4.2.2.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)
4.2.3. Immuno-FOB agglutination test
4.2.3.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)
4.2.4. Lateral flow immuno-FOB test
4.2.4.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)
4.2.5. Immuno-FOB ELISA test
4.2.5.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)
4.3. Biomarker test
4.3.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)
4.3.2. Tumor M2-PK stool test
4.3.2.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)
4.3.3. Transferrin assays
4.3.3.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)
4.4. CRC DNA screening test
4.4.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)
4.4.2. Methylated gene test
4.4.2.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)
4.4.3. Panel DNA test
4.4.3.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)
Chapter 5. In-Vitro Colorectal Cancer Screening Tests Market, By Region
5.1. Key segment trends
5.2. North America
5.2.1. Market estimates and forecast, by country, 2014 - 2025 (USD Million)
5.2.2. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
5.2.2.1. Market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
5.2.2.2. Market estimates and forecast, by biomarker test, 2014 - 2025 (USD Million)
5.2.2.3. Market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
5.2.3. U.S.
5.2.3.1. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
5.2.3.1.1. Market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
5.2.3.1.2. Market estimates and forecast, by biomarker test, 2014 - 2025 (USD Million)
5.2.3.1.3. Market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
5.2.4. Canada
5.2.4.1. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
5.2.4.1.1. Market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
5.2.4.1.2. Market estimates and forecast, by biomarker test, 2014 - 2025 (USD Million)
5.2.4.1.3. Market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
5.3. Europe
5.3.1. Market estimates and forecast, by country, 2014 - 2025 (USD Million)
5.3.2. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
5.3.2.1. Market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
5.3.2.2. Market estimates and forecast, by biomarker test, 2014 - 2025 (USD Million)
5.3.2.3. Market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
5.3.3. Germany
5.3.3.1. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
5.3.3.1.1. Market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
5.3.3.1.2. Market estimates and forecast, by biomarker test, 2014 - 2025 (USD Million)
5.3.3.1.3. Market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
5.3.4. UK
5.3.4.1. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
5.3.4.1.1. Market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
5.3.4.1.2. Market estimates and forecast, by biomarker test, 2014 - 2025 (USD Million)
5.3.4.1.3. Market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
5.3.5. France
5.3.5.1. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
5.3.5.1.1. Market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
5.3.5.1.2. Market estimates and forecast, by biomarker test, 2014 - 2025 (USD Million)
5.3.5.1.3. Market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
5.3.6. Italy
5.3.6.1. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
5.3.6.1.1. Market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
5.3.6.1.2. Market estimates and forecast, by biomarker test, 2014 - 2025 (USD Million)
5.3.6.1.3. Market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
5.3.7. Spain
5.3.7.1. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
5.3.7.1.1. Market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
5.3.7.1.2. Market estimates and forecast, by biomarker test, 2014 - 2025 (USD Million)
5.3.7.1.3. Market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
5.4. Asia Pacific
5.4.1. Market estimates and forecast, by country, 2014 - 2025 (USD Million)
5.4.2. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
5.4.2.1. Market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
5.4.2.2. Market estimates and forecast, by biomarker test, 2014 - 2025 (USD Million)
5.4.2.3. Market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
5.4.3. Japan
5.4.3.1. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
5.4.3.1.1. Market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
5.4.3.1.2. Market estimates and forecast, by biomarker test, 2014 - 2025 (USD Million)
5.4.3.1.3. Market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
5.4.4. China
5.4.4.1. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
5.4.4.1.1. Market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
5.4.4.1.2. Market estimates and forecast, by biomarker test, 2014 - 2025 (USD Million)
5.4.4.1.3. Market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
5.4.5. India
5.4.5.1. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
5.4.5.1.1. Market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
5.4.5.1.2. Market estimates and forecast, by biomarker test, 2014 - 2025 (USD Million)
5.4.5.1.3. Market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
5.4.6. Australia
5.4.6.1. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
5.4.6.1.1. Market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
5.4.6.1.2. Market estimates and forecast, by biomarker test, 2014 - 2025 (USD Million)
5.4.6.1.3. Market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
5.5. Latin America
5.5.1. Market estimates and forecast, by country, 2014 - 2025 (USD Million)
5.5.2. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
5.5.2.1. Market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
5.5.2.2. Market estimates and forecast, by biomarker test, 2014 - 2025 (USD Million)
5.5.2.3. Market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
5.5.3. Brazil
5.5.3.1. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
5.5.3.1.1. Market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
5.5.3.1.2. Market estimates and forecast, by biomarker test, 2014 - 2025 (USD Million)
5.5.3.1.3. Market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
5.5.4. Mexico
5.5.4.1. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
5.5.4.1.1. Market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
5.5.4.1.2. Market estimates and forecast, by biomarker test, 2014 - 2025 (USD Million)
5.5.4.1.3. Market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
5.6. MEA
5.6.1. Market estimates and forecast, by country, 2014 - 2025 (USD Million)
5.6.2. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
5.6.2.1. Market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
5.6.2.2. Market estimates and forecast, by biomarker test, 2014 - 2025 (USD Million)
5.6.2.3. Market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
5.6.3. South Africa
5.6.3.1. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
5.6.3.1.1. Market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
5.6.3.1.2. Market estimates and forecast, by biomarker test, 2014 - 2025 (USD Million)
5.6.3.1.3. Market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
5.6.4. Saudi Arabia
5.6.4.1. Market estimates and forecast, by test type, 2014 - 2025 (USD Million)
5.6.4.1.1. Market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
5.6.4.1.2. Market estimates and forecast, by biomarker test, 2014 - 2025 (USD Million)
5.6.4.1.3. Market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
Chapter 6. Company Profiles
6.1. Abbott Molecular Inc.
6.1.1. Business overview
6.1.2. Financial data
6.1.3. Product landscape
6.1.4. Strategic outlook
6.1.5. SWOT analysis
6.2. Alere Inc.
6.2.1. Business overview
6.2.2. Financial data
6.2.3. Product landscape
6.2.4. Strategic outlook
6.2.5. SWOT analysis
6.3. Beckman Coulter Inc.
6.3.1. Business overview
6.3.2. Financial data
6.3.3. Product landscape
6.3.4. Strategic outlook
6.3.5. SWOT analysis
6.4. Eiken Chemical
6.4.1. Business overview
6.4.2. Financial data
6.4.3. Product landscape
6.4.4. Strategic outlook
6.4.5. SWOT analysis
6.5. Epigenomics AG Corporation
6.5.1. Business overview
6.5.2. Financial data
6.5.3. Product landscape
6.5.4. Strategic outlook
6.5.5. SWOT analysis
6.6. Sysmex Corporation
6.6.1. Business overview
6.6.2. Financial data
6.6.3. Product landscape
6.6.4. Strategic outlook
6.6.5. SWOT analysis
6.7. Siemens Healthcare
6.7.1. Business overview
6.7.2. Financial data
6.7.3. Product landscape
6.7.4. Strategic outlook
6.7.5. SWOT analysis
6.8. Quest Diagnostics Incorporated
6.8.1. Business overview
6.8.2. Financial data
6.8.3. Product landscape
6.8.4. Strategic outlook
6.8.5. SWOT analysis
6.9. CompanianDx
6.9.1. Business overview
6.9.2. Financial data
6.9.3. Product landscape
6.9.4. Strategic outlook
6.9.5. SWOT analysis
6.10. OncoCyte Corporation-Biotime
6.10.1. Business overview
6.10.2. Financial data
6.10.3. Product landscape
6.10.4. Strategic outlook
6.10.5. SWOT analysis
6.11. Merck Millipore
6.11.1. Business overview
6.11.2. Financial data
6.11.3. Product landscape
6.11.4. Strategic outlook
6.11.5. SWOT analysis
6.12. GeneNews Ltd.
6.12.1. Business overview
6.12.2. Financial data
6.12.3. Product landscape
6.12.4. Strategic outlook
6.12.5. SWOT analysis
6.13. BioMarCare Technologies Ltd
6.13.1. Business overview
6.13.2. Financial data
6.13.3. Product landscape
6.13.4. Strategic outlook
6.13.5. SWOT analysis
6.14. Immunostics Inc.
6.14.1. Business overview
6.14.2. Financial data
6.14.3. Product landscape
6.14.4. Strategic outlook
6.14.5. SWOT analysis
6.15. ExiQon
6.15.1. Business overview
6.15.2. Financial data
6.15.3. Product landscape
6.15.4. Strategic outlook
6.15.5. SWOT analysis
6.16. Kyowa Medex Co. Ltd.
6.16.1. Business overview
6.16.2. Financial data
6.16.3. Product landscape
6.16.4. Strategic outlook
6.16.5. SWOT analysis
6.17. Mode Diagnostics
6.17.1. Business overview
6.17.2. Financial data
6.17.3. Product landscape
6.17.4. Strategic outlook
6.17.5. SWOT analysis
6.18. Randox Laboratories Ltd
6.18.1. Business overview
6.18.2. Financial data
6.18.3. Product landscape
6.18.4. Strategic outlook
6.18.5. SWOT analysis
6.19. R-Biopharm Incorporation
6.19.1. Business overview
6.19.2. Financial data
6.19.3. Product landscape
6.19.4. Strategic outlook
6.19.5. SWOT analysis
Data Tables
TABLE 1. In-vitro colorectal cancer screening test industry 360 degree synopsis, 2014 - 2025
TABLE 2. Global In-Vitro colorectal cancer screening tests market, 2014 - 2018 (USD Million)
TABLE 3. Global In-Vitro colorectal cancer screening tests market, 2019 - 2025 (USD Million)
TABLE 4. Global In-Vitro colorectal cancer screening tests market, by test type, 2014 - 2025 (USD Million)
TABLE 5. Global In-Vitro colorectal cancer screening tests market, by region, 2014 - 2025 (USD Million)
TABLE 6. Industry impact forces
TABLE 7. Guideline for various patient group
TABLE 8. Fecal occult blood test market estimates and forecast, by region, 2014 - 2025 (USD Million)
TABLE 9. Guaiac FOB stool test market estimates and forecast, by region, 2014 - 2025 (USD Million)
TABLE 10. Immuno-FOB agglutination test market estimates and forecast, by region, 2014 - 2025 (USD Million)
TABLE 11. Lateral flow immuno-FOB test market estimates and forecast, by region, 2014 - 2025 (USD Million)
TABLE 12. Immuno-FOB ELISA test market estimates and forecast, by region, 2014 - 2025 (USD Million)
TABLE 13. Biomarker test market estimates and forecast, by region, 2014 - 2025 (USD Million)
TABLE 14. Tumor M2-PK stool test market estimates and forecast, by region, 2014 - 2025 (USD Million)
TABLE 15. Transferrin assays market estimates and forecast, by region, 2014 - 2025 (USD Million)
TABLE 16. CRC DNA screening test market estimates and forecast, by region, 2014 - 2025 (USD Million)
TABLE 17. Methylated gene test market estimates and forecast, by region, 2014 - 2025 (USD Million)
TABLE 18. Panel DNA test market estimates and forecast, by region, 2014 - 2025 (USD Million)
TABLE 19. North America In-Vitro colorectal cancer screening tests market estimates and forecast, by country, 2014 - 2025 (USD Million)
TABLE 20. North America In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)
TABLE 21. North America In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
TABLE 22. North America In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)
TABLE 23. North America In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
TABLE 24. U.S. In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)
TABLE 25. U.S. In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
TABLE 26. U.S. In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)
TABLE 27. U.S. In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
TABLE 28. Canada In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)
TABLE 29. Canada In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
TABLE 30. Canada In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)
TABLE 31. Canada In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
TABLE 32. Europe In-Vitro colorectal cancer screening tests market estimates and forecast, by country, 2014 - 2025 (USD Million)
TABLE 33. Europe In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)
TABLE 34. Europe In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
TABLE 35. Europe In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)
TABLE 36. Europe In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
TABLE 37. Germany In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)
TABLE 38. Germany In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
TABLE 39. Germany In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)
TABLE 40. Germany In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
TABLE 41. UK In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)
TABLE 42. UK In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
TABLE 43. UK In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)
TABLE 44. UK In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
TABLE 45. France In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)
TABLE 46. France In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
TABLE 47. France In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)
TABLE 48. France In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
TABLE 49. Italy In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)
TABLE 50. Italy In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
TABLE 51. Italy In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)
TABLE 52. Italy In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
TABLE 53. Spain In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)
TABLE 54. Spain In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
TABLE 55. Spain In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)
TABLE 56. Spain In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
TABLE 57. Asia Pacific In-Vitro colorectal cancer screening tests market estimates and forecast, by country, 2014 - 2025 (USD Million)
TABLE 58. Asia Pacific In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)
TABLE 59. Asia Pacific In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
TABLE 60. Asia Pacific In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)
TABLE 61. Asia Pacific In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
TABLE 62. Japan In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)
TABLE 63. Japan In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
TABLE 64. Japan In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)
TABLE 65. Japan In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
TABLE 66. Estimated New Cancer Cases and Deaths (Thousands) by Age Groups, 2015
TABLE 67. China In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)
TABLE 68. China In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
TABLE 69. China In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)
TABLE 70. China In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
TABLE 71. India In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)
TABLE 72. India In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
TABLE 73. India In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)
TABLE 74. India In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
TABLE 75. Australia In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)
TABLE 76. Australia In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
TABLE 77. Australia In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)
TABLE 78. Australia In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
TABLE 79. Latin America In-Vitro colorectal cancer screening tests market estimates and forecast, by country, 2014 - 2025 (USD Million)
TABLE 80. Latin America In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)
TABLE 81. Latin America In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
TABLE 82. Latin America In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)
TABLE 83. Latin America In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
TABLE 84. Brazil In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)
TABLE 85. Brazil In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
TABLE 86. Brazil In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)
TABLE 87. Brazil In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
TABLE 88. Mexico In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)
TABLE 89. Mexico In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
TABLE 90. Mexico In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)
TABLE 91. Mexico In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
TABLE 92. MEA In-Vitro colorectal cancer screening tests market estimates and forecast, by country, 2014 - 2025 (USD Million)
TABLE 93. MEA In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)
TABLE 94. MEA In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
TABLE 95. MEA In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)
TABLE 96. MEA In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
TABLE 97. South Africa In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)
TABLE 98. South Africa In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
TABLE 99. South Africa In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)
TABLE 100. South Africa In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
TABLE 101. Saudi Arabia In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)
TABLE 102. Saudi Arabia In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)
TABLE 103. Saudi Arabia In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)
TABLE 104. Saudi Arabia In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
Charts & Figures
FIG 1. Industry segmentation
FIG 2. Global in-vitro colorectal cancer screening tests market, 2014- 2025 (USD Million)
FIG 3. Growth potential analysis, by test type
FIG 4. Porter's analysis
FIG 5. Strategy dashboard
FIG 6. PESTEL analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report